Improve Outcomes for Older Allogeneic Transplant Recipients

Allogeneic Transplantation Clinical Trial

Official title:
Intervening on Frailty to Improve Outcomes for Older Allogeneic Transplant Recipients

Status Recruiting

Clinical Trial Summary

This is an interventional pilot study to determine whether implementation of a supervised exercise program can improve outcomes in subjects undergoing allogeneic HCT. The primary objective is to determine feasibility. Up to 60-72 evaluable subjects will be enrolled. Evaluable subjects are defined as those participating in the exercise intervention.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Allogeneic Transplantation

Clinical Trial Details

NCT number	NCT05612789
Study type	Interventional
Source	Abramson Cancer Center at Penn Medicine
Contact	Jacqui Rick
Phone	2152209675
Email	Jacqui.Rick@pennmedicine.upenn.edu
Status	Recruiting
Phase	N/A
Start date	February 15, 2023
Completion date	November 1, 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01440556` - Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma	N/A
Unknown status	`NCT00460447` - Gemtuzumab Ozogamicin Before Allogeneic Stem Cell Transplantation	Phase 1/Phase 2
Recruiting	`NCT06450353` - Prospective Evaluation of Disparities in Provision of Allogeneic Transplantation
Recruiting	`NCT00129155` - MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies	Phase 2